rubidium has been researched along with Brain Injuries in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hahn, MG; Hinz, V; Hofmann, HA; Horváth, E; Mauler, F; Schuhmacher, J; Urbahns, K; Wirtz, S | 1 |
1 other study(ies) available for rubidium and Brain Injuries
| Article | Year |
|---|---|
Selective intermediate-/small-conductance calcium-activated potassium channel (KCNN4) blockers are potent and effective therapeutics in experimental brain oedema and traumatic brain injury caused by acute subdural haematoma.
Topics: Animals; Brain Chemistry; Brain Edema; Brain Injuries; Calcimycin; Cell Line, Tumor; Cerebral Infarction; Charybdotoxin; Clotrimazole; DNA Primers; Erythrocytes; Glioma; Hematoma, Subdural; Humans; Intermediate-Conductance Calcium-Activated Potassium Channels; Potassium Channel Blockers; Potassium Channels, Calcium-Activated; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; Rubidium; Water | 2004 |